Biosynex S.A. (ALBIO.PA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-245.0%

-€1.18

vs €0.81 price

Levered DCF

-€6.09

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

0.8

Distress zone

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.19×	-0.43×	-2.42×	9.05×	2.61×	4×	17.92×	34.68×
P/B	0.34×	0.23×	0.72×	0.72×	1.34×	1.89×	0.65×	0.64×
P/S	0.12×	0.18×	0.96×	0.59×	0.59×	0.82×	0.57×	0.6×
EV / EBITDA	7.57×	-28.61×	-13.25×	1.58×	0.9×	2.01×	16.91×	26.41×
Gross margin	-3.8%	-19.8%	52.8%	32.8%	47.7%	31.3%	5.4%	28.0%
Operating margin	-4.9%	-20.8%	-40.2%	19.8%	36.8%	29.7%	3.2%	1.2%
Net margin	-61.1%	-42.8%	-39.7%	8.0%	27.2%	20.4%	3.2%	1.7%
Current ratio	1.94×	0.75×	2.24×	4.03×	3.24×	1.9×	1.81×	2.37×
Debt / equity	1.9×	0.78×	0.53×	0.32×	0.21×	0.24×	0.33×	0.18×
Interest coverage	-1.06×	-3.4×	-14.18×	77.57×	384.86×	203.88×	5.83×	1.86×
Dividend yield	0.0%	0.0%	0.0%	17.5%	0.9%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	130.6%	1.9%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-179.4%	-53.7%	-29.7%	9.6%	62.0%	47.3%	3.6%	1.9%
Return on invested capital	-4.1%	-13.0%	-16.9%	11.0%	50.0%	38.3%	2.7%	1.1%
Return on assets	-42.7%	-22.2%	-15.3%	6.0%	38.7%	24.9%	2.3%	1.4%
Free cash flow yield	-76.7%	-80.9%	-55.0%	-21.5%	40.5%	17.9%	5.6%	2.5%
Earnings yield	-520.9%	-234.0%	-41.3%	13.4%	46.4%	25.0%	5.6%	2.9%
Enterprise value	€64.4M	€76.3M	€134.9M	€81.8M	€127.6M	€104.4M	€27.8M	€22.2M
Net debt / EBITDA	6.26×	-21.67×	-4.46×	-0.68×	-0.68×	-0.41×	4.94×	3.97×
Cash conversion cycle (days)	93	170	234	90	47	72	88	90